GRAIN, Prospective Pilot Study
The GRAIN study is an early-stage research project for people with specific changes in their food pipe, including a condition called Barrett's oesophagus, or very early signs of cancer in the food pipe, known as oesophageal dysplasia or oesophageal adenocarcinoma. This is the first time this new treatment will be tested in humans. Its main purpose is to see if it’s safe and how the body reacts to it. Because it’s so early, researchers are carefully checking for any side effects and learning important information about how the treatment works, rather than looking for a cure at this stage. It’s part of the process to find better ways to treat these conditions in the future.
At a glance
What is this study about?
Imagine your food pipe (which doctors call the oesophagus) is an important tube that carries food from your mouth to your stomach. Sometimes, the cells lining this tube can get damaged or change over time. Conditions like Barrett's oesophagus mean these cells have changed and, in some cases, these changes can become more serious, like oesophageal dysplasia (very early, abnormal cells) or even oesophageal adenocarcinoma (a type of cancer).
The GRAIN study is a very early step in finding new ways to help people with these conditions. It's what we call a 'Phase I' study, which means it's the first time the new treatment is being given to humans. Researchers need to be extremely careful at this stage, so their main focus is to understand if the treatment is safe and what effects it has on the body. They will be looking closely for any side effects and learning as much as they can about how the treatment works.
Even though this is an early study, it's a vital part of medical research. By taking these careful first steps, scientists hope to gather enough information to develop new and potentially more effective treatments for people facing these types of oesophageal conditions in the future. It helps us understand if new medicines are worth pursuing in bigger studies down the line.
Key takeaways
- This is an early-stage study (Phase I) for a new treatment.
- It's for people with certain changes in their food pipe (oesophagus).
- The main focus is to check the treatment's safety and how it works in humans.
- It's not designed to cure your condition at this early stage.
- Participation could help researchers develop future treatments.
Who may be eligible?
To be considered for the GRAIN study, you need to be at least 18 years old – there's no upper age limit. Both men and women are welcome to take part in this research.
The study is specifically looking for people who have been diagnosed with certain changes in their food pipe. This includes oesophageal adenocarcinoma (a type of cancer in the food pipe), Barrett's oesophagus (where the lining of the food pipe has changed), or oesophageal dysplasia (which means there are abnormal cells in the food pipe that could potentially lead to cancer).
If you have one of these conditions and are over 18, the research team would consider you. However, there will be other health checks and criteria to ensure the study is right for you and that taking part would be safe. These details will be discussed fully by the study doctors.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you have oesophageal adenocarcinoma, Barrett's oesophagus, or oesophageal dysplasia?
- Are you able to attend regular clinic visits?
- Are you comfortable with receiving an experimental new treatment?
What does participation involve?
Taking part in the GRAIN study would involve several visits to the clinic. At these visits, you would have medical examinations, blood tests, and potentially other tests to see how your body is reacting to the new treatment. You would receive the study treatment as instructed by the medical team. There will be a period of close monitoring after you start the treatment to make sure you are safe and to understand any effects of the drug. The research team will explain the specific schedule of visits, how long each part of the study will last, and the total duration of your involvement, including any follow-up appointments after the treatment ends. You will be told exactly what to expect from beginning to end.
Potential risks and benefits
Locations (1)
- —UnverifiedNetherlands
Common questions
What is Barrett's oesophagus?
Barrett's oesophagus is a condition where the normal lining of your food pipe changes to a type of cell usually found in the gut. While not cancerous itself, it can sometimes increase the risk of developing oesophageal cancer.
What does 'Phase I study' mean?
A Phase I study is the first time a new treatment is given to humans. The main goal is to find out if it's safe and what dose can be given, rather than how well it treats the condition at this very early stage.
Will this study cure my condition?
Because this is a very early-stage study, it's not designed to find a cure. Its main purpose is to test the safety of the new treatment and how your body reacts to it. Finding a cure would be a goal for much later studies.
How long will I be involved in the study?
The study team will tell you the exact duration of your involvement, including how many visits you'll need and how long any follow-up will last. It varies depending on the specific study design, but they will explain it all clearly.
Can I leave the study once I've started?
Yes, you can leave the study at any time, for any reason, without having to explain why. It will not affect your usual medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.